Kenichi Inoue
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene-related peptide-calcitonin receptor-like neuroimmune suppression in atopic dermatitis.
Journal: The Journal of allergy and clinical immunology
Published: October 23, 2025
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis.
Journal: Cancer science
Published: September 08, 2025
Development of an AI-based Positioning Technical Assistance System for Mammography
Journal: Nihon Hoshasen Gijutsu Gakkai zasshi
Published: September 07, 2025
A novel quantification method for automatic computation of breast density from mammography images using deep learning.
Journal: Breast cancer (Tokyo, Japan)
Published: August 31, 2025
Cultural Adaptation and Preliminary Validation of Adherence Questionnaires for Japanese Patients with Breast Cancer: A Pilot Study.
Journal: Patient preference and adherence
Published: July 11, 2025
Tissue Factor Pathway-Driven Initial Thrombin Generation is Associated with Hypercoagulability in Obesity.
Journal: Thrombosis and haemostasis
Published: March 06, 2025
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: March 05, 2025
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions - a first large-scale multi-institutional clinical trial in Japan.
Journal: Breast cancer (Tokyo, Japan)
Published: January 21, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer.
Journal: Endocrine-related cancer
Published: December 26, 2024
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).
Journal: Breast cancer (Tokyo, Japan)
Published: September 20, 2024
Last Updated: 09/26/2026